c-Jun N-terminal protein kinase signalling pathway mediates lovastatin-induced rat brain neuroblast apoptosis

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1771, Issue 2, 2007, Pages 164-176

  Cerezo Guisado, Maria Isabel ^a   Álvarez Barrientos, Alberto ^b   Argent, Ricardo ^a   García Marín, Luis Jesús ^a   Bragado, Maria Julia ^a   Lorenzo, Maria Jesús ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Apoptosis; Bim; JNK; Nervous system; p38 MAPK; Statins

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MEVALONIC ACID; MEVINOLIN; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; NEUROBLAST; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

RATTUS;

EID: 33846799237     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2006.12.002     Document Type: Article

References (65)

1. Chen H.W. Role of cholesterol metabolism in cell growth. Fed. Proc. 43 (1984) 126-130
2. Goldstein J.L., and Brown M.S. Regulation of the mevalonate pathway. Nature 343 (1990) 425-429
3. Grunler J., Ericsson J., and Dallner G. Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins. Biochim. Biophys. Acta 1212 (1994) 259-277
4. Padayatty S.J., Marcelli M., Shao T.C., and Cunningham G.R. Lovastatin-induced apoptosis in prostate stromal cells. J. Clin. Endocrinol. Metabol. 82 (1997) 1434-1439
5. Blanco-Colio L.M., Villa A., Ortego M., Hernández-Presa M.A., Pascual A., Plaza J.J., and Egido J. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation. Atherosclerosis 161 (2002) 17-26
6. Hillyard D.Z., Cameron A.J., McIntyre A.H., Hadden N.H., Marshall C.E., Johnston N., and Jardine A.G. Inhibition of proliferation and signalling mechanisms in human lymphocytes by fluvastatin. Clin. Exp. Pharmacol. Physiol. 29 (2002) 673-678
7. Jaster R., Brock P., Sparmann G., Emmrich J., and Liebe S. Inhibition of pancreatic stellate cell activation by the hydroxymethylglutaryl coenzyme A reductase inhibitor lovastatin. Biochem. Pharmacol. 65 (2003) 1295-1303
8. Graaf M.R., Richel D.J., van Noorden C.J.F., and Guchelarr H.J. Effect of statins and farnesyltransferase inhibitors on the development and progression of cancer. Cancer Treat. Rev. 30 (2004) 609-641
9. Koyuturk M., Ersoz M., and Altiok N. Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-terminal kinase. Neurosci. Lett. 370 (2004) 212-217
10. Takata R., Fukasawa S., Hara T., Nakajima H., Yamashina A., Yanase N., and Nizuguchi J. Cerivastatin-induced apoptosis of human aortic smooth muscle cells through partial inhibition of basal activation of extracellular signal-regulated kinases. Cardiovasc. Pathol. 13 (2004) 41-48
11. Wu J., Wong W.W., Khosravi F., Minden M.D., and Penn L.Z. Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukaemia cells to lovastatin-induced apoptosis. Cancer Res. 64 (2004) 6461-6468
12. Kaneta S., Satoh K., Kano S., Kanda M., and Ichihara K. All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells. Atheroscleoris 17 (2003) 237-243
13. Maltese W.A., and Volpe J.J. Developmental changes in the distribution of 3-hydroxy-3-methylglutaryl coenzyme A reductase among subcellular fractions of rat brain. J. Neurochem. 33 (1979) 107-115
14. Spady D.K., and Dietschy J.M. Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster and rat. J. Lipids Res. 24 (1983) 303-315
15. Cavender C.P., Turley S.D., and Dietschy J.M. Sterol metabolism in fetal, newborn and suckled lambs and their response to cholesterol after weaning. Am. J. Physiol. 269 (1995) E331-E340
16. Edison R.J., and Muenke M. Central nervous system and limb anomalies in case reports of first-trimester statin exposure. N. Engl. J. Med. 350 (2004) 1579-1582
17. Edison R.J., and Muenke M. Mechanistic epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins. Am. J. Med. Genet. 131A (2004) 287-298
18. Michikawa M., and Yanagisawa K. Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death. J. Neurochem. 72 (1999) 2278-2285
19. Tanaka T., Tatsuno I., Uchida D., Moroo I., Morio H., Nakamura S., Noguchi Y., Yasuda T., Kitagawa M., Saito Y., and Hirai A. Geranylgeranyl-pirophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition. J. Neurosci. 20 (2000) 2852-2859
20. Schulz J.G., Bosel J., Stoeckel M., Megow D., Dirnagl U., and Endres M. HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis. J. Neurochem. 89 (2004) 24-32
21. García-Román N., Álvarez A.M., Toro M.J., Montes A., and Lorenzo M.J. Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: involvement of nonsterol isoprenoid biosynthesis inhibition. Mol. Cell Neurosci. 17 (2001) 329-341
22. Lossi L., and Merighi A. In vivo cellular and molecular mechanisms of neuronal apoptosis in the mammalian CNS. Prog. Neurobiol. 69 (2003) 287-312
23. De Zio D., Giunta L., Corvazo M., Ferraro E., and Cecconi F. Expanding roles of programmed cell death in mammalian neurodevelopment. Semin. Cell Dev. Biol. 16 (2005) 281-294
24. Stefanis L., Burke R.E., and Greene L.A. Apoptosis in neurodegenerative disorders. Curr. Opin. Neurol. 10 (1997) 299-305
25. Mielke K., and Herdegen T. JNK and p38 stress kinases-degenerative effectors of signal-transduction-cascades in the nervous system. Prog. Neurobiol. 61 (2000) 45-60
26. Harper S.J., and LoGrasso P. Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38. Cell. Signal. 13 (2001) 299-310
27. Waetzig V., and Herdegen T. Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage. Trends Pharmacol. Sci. 26 (2005) 455-461
28. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
29. Le-Niculescu H., Bonfoco E., Kasuya Y., Claret F.-X., Green D.R., and Karin M. Withdrawal of survival factors results in activation of JNK pathway in neuronal cells leading to Fas Ligand induction and cell death. Mol. Cell. Biol. 19 (1999) 751-763
30. Lambeng N., Willaime-Morawek S., Mariani J., Ruberg M., and Brugg B. Activation of mitogen-activated protein kinase pathways during the death of PC12 cells is dependent on the state of differentiation. Mol. Brain Res. 111 (2003) 52-60
31. Cao J., Semenova M.M., Solovyan V.T., Han J., and Coffey E.L.T. Distinct requirements for p38α and c-Jun N-terminal kinase stress-activated protein kinases in different forms of apoptotic neuronal death. J. Biol. Chem. 279 (2004) 35903-35913
32. Willaime-Moravek S., Brami-Cherrier K., Mariani J., Caboche J., and Brugg B. c-Jun N-terminal kinases/c-Jun and p38 pathways cooperate in ceramide-induced neuronal apoptosis. Neuroscience 119 (2003) 387-397
33. Sarker K.P., Biswas K.K., Yamakuchi M., Lee R.-Y., Hahiguchi T., Kracht M., Kitajima I., and Maruyama I. ASK-1-p38 MAPK/JNK signaling cascade mediates anandamide-induced PC12 cell death. J. Neurochem. 85 (2003) 50-61
34. Kim S.D., Moon C.K., Eun S.-Y., Ryu P.D., and Jo S.A. Identification of ASK1, MKK4, JNK, c-Jun and caspase-3 as a signaling cascade involved in cadmium-induced neuronal cell apoptosis. Biochem. Biophys. Res. Commun. 328 (2005) 326-334
35. Namgung U., and Xia Z. Arsenite-induced apoptosis in cortical neurons is mediated by c-Jun-N-terminal protein kinase 3 and p38 mitogen-activated protein kinase. J. Neurosci. 20 (2000) 6442-6451
36. Gunn-Moore F.J., and Tavare J.M. Apoptosis of cerebellar granule cells induced by serum withdrawal, glutamate or beta-amyloid, is independent of Jun kinase or p38 mitogen activated protein kinase activation. Neurosci. Lett. 250 (1998) 53-56
37. Eilers A., Whitfield J., Babij C., Rubin L.L., and Ham J. Role of the Jun kinase pathway in the regulation of c-Jun expression and apoptosis in sympathetic neurons. J. Neurosci. 18 (1998) 1713-1724
38. Anderson C.N.G., and Tolkovsky A.M. A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNK independent induction of apoptosis by cytosine arabinoside. J. Neurosci. 19 (1999) 664-673
39. Mao Z., Bonni A., Xia F., Nadal-Vicens M., and Greenberg M.E. Neuronal activity dependent cell survival mediated by transcription factor MEF2. Science 286 (1999) 785-790
40. Leppa S., Saffrich R., Ansorge W., and Bohmann D. Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. EMBO J. 17 (1998) 4404-4413
41. Morooka T., and Nishida E. Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J. Biol. Chem. 273 (1998) 24285-24288
42. Ham J., Eilers A., Whitfield J., Neame S.J., and Shah B. c-Jun and the transcriptional control of neuronal apoptosis. Biochem. Pharmacol. 60 (2000) 1015-1021
43. Watson A., Eliers A., Lallemand D., Kyriakis J., Rubin L.L., and Ham J. Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons. J. Neurosci. 18 (1998) 751-762
44. Schulz J.B., Weller M., and Klockgether T. Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement of new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J. Neurosci. 16 (1996) 4696-4706
45. Ham J., Babij C., Whitfield J., Pfarr C.M., Lallemand D., Yaniv M., and Rubin L.L. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14 (1995) 927-939
46. EL signalling pathway in neuronal apoptosis. J. Neurosci. 24 (2004) 8762-8770
47. Harris C.A., and Jonhson Jr. E.M. BH3-only Bcl-2 Family Members are co-ordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. J. Biol. Chem. 276 (2001) 37754-37760
48. Zhang F.L., and Casey P.J. Protein prenylation: molecular mechanisms and functional consequences. Ann. Rev. Biochem. 65 (1996) 241-269
49. Kita T., Brown M.S., and Goldstein J.L. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevilonin, a competitive inhibitor of the reductase. J. Clin. Invest. 66 (1980) 1094-1100
50. Muñoz A., Wrighton C., Seliger B., Bernal J., and Beug H. Thyroid hormone receptor/c-erbA: control of commitment and differentiation in the neuronal/chromaffin progenitor line PC12. J. Cell Biol. 121 (1993) 423-438
51. Bonny C., Oberson A., Negri S., Sauser C., and Schorderet D.F. Cell-permeable peptide inhibitors of JNK. Novel blockers of beta-cell death. Diabetes 50 (2001) 77-82
52. Jiang Z., Zheng X., Lytle R.A., Higashikubo R., and Rich K.M. Lovastatin-induced up-regulation of the BH3-only protein, Bim, and cell death in glioblastoma cells. J. Neurochem. 89 (2004) 168-178
53. Otsuki T., Sakaguchi H., Hatayama T., Fujii T., Tsujioka T., Sugihara T., Takata A., Hyodoh F., and Eto M. Effects of an HMG-CoA reductase inhibitor, simvastatin, on human myeloma cells. Oncol. Rep. 11 (2004) 1053-1058
54. Cerezo-Guisado M.I., García-Marín L.J., Lorenzo M.J., and Bragado M.J. Lovastatin inhibits the growth and survival pathway of phosphoinositide 3-kinase/protein kinase B in immortalized rat brain neuroblasts. J. Neurochem. 94 (2005) 1277-1287
55. Shimoke K., Yamagishi S., Yamada M., Ikeuchi T., and Hatanaka H. Inhibition of phosphatidylinositol 3-kinase activity elevates c-Jun-N-terminal kinase activity in apoptosis of cultured cerebellar granule neurons. Dev. Brain Res. 112 (1999) 245-253
56. Kim A.H., Yano H., Cho H., Meyer D., Monks B., Margolis B., Birnabaum M.J., and Chao M.V. Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron 35 (2002) 697-709
57. Vojtek A.B., and Cooper J.A. Rho family members: activators of MAP kinase cascades. Cell 82 (1995) 527-529
58. Merry D.E., and Korsmeyer S.J. Bcl-2 gene family in the nervous system. Annu. Rev. Neurosci. 20 (1997) 245-267
59. Putcha G.V., Le S., Frank F., Bersili C.G., Clark K., Chu B., Alix S., Youle R.J., LaMarche A., Maroney A.C., and Johnson Jr. E.M. JNK-mediated Bim phosphorylation potentiates Bax-dependent apoptosis. Neuron 38 (2003) 899-914
60. Le S.S., Loucks F.A., Udo H., Richardson-Burns S., Phelps R.A., Bouchard R.J., Barth H., Aktories K., Tyler K.L., Kandel E.R., Heidenreich K.A., and Linseman D.A. Inhibition of Rac GTPase triggers a c-Jun- and Bim-dependent mitochondrial apoptotic cascade in cerebellar granule neurons. J. Neurochem. 94 (2005) 1025-1039
61. Okuno S., Saito A., Hayashi T., and Chan P.H. The c-Jun N-terminal protein kinase signaling pathway mediates Bax activation and subsequent neuronal apoptosis through interaction with Bim alters transient focal cerebral ischemia. J. Neurosci. 24 (2004) 7879-7887
62. Yoon S., Choi J., Yoon J., Huh J.-W., and Kim D. Okadaic acid induces JNK activation, Bim overexpression and mitochondrial dysfunction in cultured rat cortical neurons. Neurosci. Let. 394 (2006) 190-195
63. Stepien K., Tomaszewski M., and Czuczwar S.J. Neuroprotective properties of statins. Pharmacol. Rep. 57 (2005) 561-569
64. Bösel J., Gandor F., Harás C., Synowitz M., Harás U., Djoufack P.C., Megow D., Dirnagl U., Hörtnagl H., Fink K.B., and Endres M. Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones. J. Neurochem. 92 (2005) 1386-1398
65. Zacco A., Togo J., Spence K., Ellis A., Lloyd D., Furlong S., and Piser T. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J. Neurosci. 23 (2003) 11104-11111